Suppr超能文献

中国公众对新冠病毒加强疫苗接种的认知与接受度:一项横断面研究

Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study.

作者信息

Lai Xiaozhen, Zhu He, Wang Jiahao, Huang Yingzhe, Jing Rize, Lyu Yun, Zhang Haijun, Feng Huangyufei, Guo Jia, Fang Hai

机构信息

School of Public Health, Peking University, Beijing 100191, China.

China Center for Health Development Studies, Peking University, Beijing 100191, China.

出版信息

Vaccines (Basel). 2021 Dec 10;9(12):1461. doi: 10.3390/vaccines9121461.

Abstract

Coronavirus disease 2019 (COVID-19) booster vaccination has been proposed in response to the new challenges of highly contagious variants, yet few studies have examined public acceptance of boosters. This study examined public acceptance of COVID-19 booster vaccination and its influencing factors by using the data from a self-administered online cross-sectional survey conducted in June 2021 in China. Multiple logistic analysis was used to examine the influencing factors of booster acceptance based on the health belief model (HBM). Among 1145 respondents, 84.80% reported to accept COVID-19 booster vaccination. Having COVID-19 vaccination history, perceiving high benefits and low barriers to booster vaccination, being younger (18-30 vs. 41-50), having a lower education level, being employed, and belonging to priority groups for vaccination were associated with increased odds of booster acceptance. The primary reason for refusing booster vaccination was concern about vaccine safety. The vast majority (92.8%) of respondents reported an annual willingness to pay between 0 and 300 CNY (0-46.29 USD) if the booster was not free. Our findings suggest that the acceptance rate of booster vaccination is relatively high in China, and the HBM-based analysis reveals that more efforts are needed to increase perceived benefits and reduce perceived barriers of vaccination to design effective and proper vaccination extension strategies when boosters become widely recommended.

摘要

为应对高传染性变种带来的新挑战,已提议开展2019冠状病毒病(COVID-19)加强疫苗接种,但很少有研究考察公众对加强针的接受度。本研究利用2021年6月在中国进行的一项自填式在线横断面调查数据,考察了公众对COVID-19加强疫苗接种的接受度及其影响因素。基于健康信念模型(HBM),采用多元逻辑分析来考察加强针接受度的影响因素。在1145名受访者中,84.80%报告接受COVID-19加强疫苗接种。有COVID-19疫苗接种史、认为加强疫苗接种的益处高且障碍低、年龄较小(18 - 30岁与41 - 50岁相比)、教育水平较低、有工作以及属于疫苗接种优先群体与加强针接受度增加的几率相关。拒绝加强疫苗接种的主要原因是担心疫苗安全性。如果加强针不免费,绝大多数(92.8%)受访者报告每年愿意支付0至300元人民币(0至46.29美元)。我们的研究结果表明,在中国加强疫苗接种的接受率相对较高,基于HBM的分析显示,当广泛推荐加强针时,需要做出更多努力来提高感知到的益处并降低感知到的接种障碍,以制定有效且合适的疫苗接种推广策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3974/8709447/510381220b84/vaccines-09-01461-g001a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验